Dr. Nayak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Ave
Baltimore, MD 21224Phone+1 410-550-0501Fax+1 443-287-9359
Education & Training
- George Washington UniversityFellowship, Infectious Disease, 2009 - 2011
- George Washington University School of Medicine and Health SciencesNon Degree, Global Health, 2009 - 2010
- University of MarylandResidency, Internal Medicine, 2006 - 2009
- George Washington University School of Medicine and Health SciencesClass of 2006
- George Washington UniversityB.S., Biology, 1998 - 2002
- George Washington UniversityB.A., Religion, 1998 - 2002
Certifications & Licensure
- MD State Medical License 2011 - 2025
- DC State Medical License 2009 - 2024
- VA State Medical License 2009 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Junior Faculty Leadership Program Johns Hopkins University, 2015
- Emerging Women's Leadership Program Johns Hopkins University, 2014
- Alpha Omega Alpha Honor Society George Washington University School of Medicine, 2006
- Join now to see all
Publications & Presentations
PubMed
- 98 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18 - 75 citationsHeterologous SARS-CoV-2 Booster Vaccinations: Preliminary ReportRobert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela Branche
Medrxiv. 2021-10-15 - 346 citationsHomologous and Heterologous Covid-19 Booster Vaccinations.Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche
The New England Journal of Medicine. 2022-03-17
Journal Articles
- Phase I Clinical Trials of DAS-181, an Inhaled Sialidase, in Healthy AdultsZenilman JM, Fuchs EJ, Hendrix CW, Radebaugh C, Jurao R, NayakSU, Hamilton RG, McLeod Griffiss J, Antiviral Research, 1/1/2015
- Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin ANayak SU, Griffiss JM, McKenzie R, Fuchs EJ, Jurao RA, An AT, Ahene A, Tomic M, Hendrix CW, Zenilman JM, Antimicrobial Agents and Chemotherapy, 1/1/2014
- No Nephrotoxicity for Tenofovir Combined with Ritonavir in Treatment of Adult HIV InfectionNayak S, Amdur R, Kan V, Journal of AIDS and HIV Research, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- "Safety and Pharmacokinetics of a Novel Co-mixture of Three Monoclonal Antibodies Against Botulism in Healthy Subjects."SU Nayak, R McKenzie, E Fuchs, R Jurao, J Goodwin, E Zimmerman, AAn, C Hendrix, Q Liu, J Ma, A Ahene, Y Espinosa, M Griffiss, J Zenilman, Abstracts of the 11th Annual Meeting of the American Society of Microbiology Biodefense and Emerging Diseases, Washington, DC, 1/1/2013
- "Renal Function in HIV-Infected Veterans on Tenofovir with and without Ritonavir."SU Nayak, M Czarnogorski, R Amdur, VL Kan, Abstracts of the 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 1/1/2011
- "Prevalence of Asymptomatic Bacterial Sexually Transmitted Infections in Hospitalized Human Immunodeficiency Virus Patients in Baltimore City."SU Nayak, AC Hodowanec, LE Fantry, Abstracts of the 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, BC, 1/21/2010
- Join now to see all
Lectures
- STIsGood Samaritan Hospital, Baltimore, MD - 1/21/2015
- MycobacteriaJohns Hopkins Bayview Medical Center, Baltimore, MD - 1/10/2014
- Pre-Exposure ProphylaxisJohns Hopkins Bayview Medical Center, Baltimore, MD - 1/7/2014
- Join now to see all
Press Mentions
- “Remdesivir for COVID-19” Study Accidentally Proved Effectiveness of HydroxychloroquineOctober 26th, 2020
Grant Support
- Phase I Clinical Trial Unit for Therapeutics Against Infectious DiseasesNIH-NIAID2015–2018
- HIV Prevention Training of ProvidersCDC2015–2016
- HIV Prevention Training of ProvidersCDC2014–2015
- Sexually Transmitted Infections Clinical Trials Grant, Task Area 1, Task Order 4NIH-NIAID2014–2015
- Phase I Clinical Trial Unit for Therapeutics Against Infectious DiseasesNIH-NIAID2008–2015
- HIV Prevention Training of ProvidersCDC2014
- HIV Prevention Training of ProvidersCDC2013–2014
- AIDS Education and Training CenterUniversity of Pittsburgh/Health Resources and Services Administration2011–2013
Committees
- Advisory Committee, Scientific Advisory Committee, 26C Contract, Clinical Research Management 2013 - 2018
External Links
- NIAID Office of Clinical Research Resourceshttps://www.niaid.nih.gov/about/clinical-research-resources-contacts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: